Physician profile
Pulin H Patel
NPI 1063535664
$6,350.04
in general payments reported to CMS, 2019-2025
21 companies · $832 in 2025
The $832 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $869 · 2020: $1,082 · 2021: $608 · 2022: $681 · 2023: $768 · 2024: $1,510 · 2025: $832.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,109.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,398.99 | 2019-2025 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $1,310.98 | 2019-2025 | Farxiga, Breztri, Tezspire |
| Amgen INC. | $434.66 | 2023-2025 | Otezla, Repatha, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $430.43 | 2021-2023 | |
| Senseonics, Incorporated | $400.00 | 2020 | |
| Abbvie INC. | $374.99 | 2024-2025 | |
| Lilly USA, LLC | $288.41 | 2019-2020 | |
| Genzyme Corporation | $248.31 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $224.46 | 2019 | |
| Medtronic, INC. | $187.50 | 2021 | |
| Abbott Laboratories | $185.09 | 2023-2024 | Freestyle Libre 3, Eterna |
| Glaxosmithkline, LLC. | $176.72 | 2023-2025 | Arexvy, Trelegy Ellipta |
| Madrigal Pharmaceuticals | $135.00 | 2025 | Rezdiffra |
| Phathom Pharmaceuticals, INC. | $125.00 | 2024 | Voquezna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.75 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $124.21 | 2019 | |
| Dexcom, INC. | $83.21 | 2024 | Dexcom G7 Gss (161) |
| Cequr Corporation | $54.21 | 2024 | Cequr Simplicity |
| Teva Pharmaceuticals USA, INC. | $15.00 | 2019 | |
| Merck Sharp & Dohme LLC | $14.88 | 2019 | |
| Exact Sciences Corporation | $13.24 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pulin Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.